Abstract

Propionylation has been identified recently as a new type of protein post-translational modification. Bacterial propionyl-CoA synthetase and human histone H4 are propionylated at specific lysine residues that have been known previously to be acetylated. However, other proteins subject to this modification remain to be identified, and the modifying enzymes involved need to be characterized. In this work, we report the discovery of histone H3 propionylation in mammalian cells. Propionylation at H3 lysine Lys(23) was detected in the leukemia cell line U937 by mass spectrometry and Western analysis using a specific antibody. In this cell line, the propionylated form of Lys(23) accounted for 7%, a level at least 6-fold higher than in other leukemia cell lines (HL-60 and THP-1) or non-leukemia cell lines (HeLa and IMR-90). The propionylation level in U937 cells decreased remarkably during monocytic differentiation, indicating that this modification is dynamically regulated. Moreover, in vitro assays demonstrated that histone acetyltransferase p300 can catalyze H3 Lys(23) propionylation, whereas histone deacetylase Sir2 can remove this modification in the presence of NAD(+). These results suggest that histone propionylation might be generated by the same set of enzymes as for histone acetylation and that selection of donor molecules (propionyl-CoA versus acetyl-CoA) may determine the difference of modifications. Because like acetyl-CoA, propionyl-CoA is an important intermediate in biosynthesis and energy production, histone H3 Lys(23) propionylation may provide a novel epigenetic regulatory mark for cell metabolism.

Highlights

  • Contribute to tumor formation such as malignant hematopoiesis [2]

  • The in vivo propionylation of propionyl-CoA synthetase is catalyzed by a protein related to GCN5 histone acetyltransferase (HAT), and the propionyl group can be removed by NADϩ-dependent human Sir2 histone deacetylase in vitro [8]

  • Because propionyl-CoA and acetyl-CoA, both metabolic products of fatty acid, are differential cofactors for dual functional histone acetyltransferases, we suggest that histone propionylation might be associated with cellular metabolic status

Read more

Summary

Introduction

Contribute to tumor formation such as malignant hematopoiesis [2]. For example, genome-wide alterations of histone modification patterns are found in prostate cancer and are predictive of clinical outcomes [3]; histone H3 Lys79 (H3K79) hypermethylation and the activation of oncogenic HOX genes are prominent causes for leukemia with chromosome translocation involving the AF10 gene [4, 5], whereas global hypomethylation at H3K79 sites has been proposed to cause genome instability in AF10-related leukemia cancers [6]. This modification was detected at H3 Lys23 (H3K23) in the myeloid precursor leukemia cell line U937. The H3K23 propionylation level in U937 cells decreased significantly during monocytic differentiation, suggesting that this modification might be associated with lineage determination.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call